Wound Infections Following Implant Removal

Last updated: December 21, 2016
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Overall Status: Completed

Phase

4

Condition

Pressure Ulcer

Treatment

N/A

Clinical Study ID

NCT02225821
SB155014
NTR 4393
  • Ages 18-75
  • All Genders

Study Summary

In the Netherlands about 18,000 surgical procedures with implant removal are annually performed after fracture healing, of which 30-80% concern the foot, ankle and lower leg region. For clean surgical procedures, the rate of postoperative wound infections (POWIs) should be less than 5%. However, rates of 10-12% following implant removal, specifically after foot, ankle and lower leg fractures are reported. Currently, surgeons decide individually if antibiotics prophylaxis is given, since no guideline exists. This leads to undesirable practice variation.

Therefore, the investigators propose a double-blind randomized controlled trial (RCT) in patients scheduled for implant removal following a foot, ankle or lower leg fracture, to assess the (cost-)effectiveness of a single gift of antibiotic prophylaxis. Primary outcome is a POWI within 30 days after implant removal. Secondary outcomes are quality of life, functional outcome at 30 days and 6 months after implant removal and costs.

With 2 x 250 patients a decrease in POWI from 10% to 3.3% (expected rate in clean-contaminated elective orthopedic trauma procedures) can be detected (Power=80%, 2-sided alpha=5%, including 15% lost to follow up).

If the assumption of the investigators, that prophylactic antibiotics prior to implant removal reduces the infectious complication rate, is confirmed by this RCT, this will offer a strong argument to adopt a single gift of antibiotic prophylaxis as standard practice of care. This will reduce the incidence of POWIs and consequently will lead to less physical and social disabilities and health care use. In addition, it will decrease the rate of use of empiric broad-spectrum antibiotics (and antibiotic resistance) prescribed upon suspicion or diagnosis of a POWI. A preliminary, conservative estimation suggests yearly cost savings in the Netherlands of €3.5 million per year.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients ≥18 years and ≤75 years of all ethnic backgrounds

  • Implant removal following foot, ankle and/or lower leg surgery

Exclusion

Exclusion Criteria:

  • Removing and re-implanting osteosynthesis material in the same session

  • Active wound infection or (plate) fistula

  • Antibiotic treatment at time of elective implant removal for a concomitant disease orinfection

  • A medical history of an allergic reaction to a cephalosporin, penicillin, or any other β-lactam antibiotic.

  • Insufficient comprehension of the Dutch language to understand the patient informationto make an informed decision to participate.

  • Kidney disease (eGFR <60 ml/min/1.73m^2).

  • Treatment with probenecide, anticoagulants (see SPC)

  • Pregnancy and lactation

Study Design

Total Participants: 500
Study Start date:
November 01, 2014
Estimated Completion Date:
November 30, 2016

Study Description

See study protocol

Connect with a study center

  • Medisch Centrum Alkmaar

    Alkmaar,
    Netherlands

    Site Not Available

  • Flevoziekenhuis

    Almere,
    Netherlands

    Site Not Available

  • Amstelland Ziekenhuis

    Amstelveen,
    Netherlands

    Site Not Available

  • Academic Medical Center

    Amsterdam,
    Netherlands

    Site Not Available

  • BovenIJ Ziekenhuis

    Amsterdam,
    Netherlands

    Site Not Available

  • Onze Lieve Vrouwe Gasthuis

    Amsterdam,
    Netherlands

    Site Not Available

  • Sint Lucas Andreas Ziekenhuis

    Amsterdam,
    Netherlands

    Site Not Available

  • VU Medisch Centrum

    Amsterdam,
    Netherlands

    Site Not Available

  • Gelre Ziekenhuizen

    Apeldoorn,
    Netherlands

    Site Not Available

  • Rode Kruis Ziekenhuis

    Beverwijk,
    Netherlands

    Site Not Available

  • Amphia Ziekenhuis

    Breda,
    Netherlands

    Site Not Available

  • Reinier de Graaf

    Delft,
    Netherlands

    Site Not Available

  • MC Haaglanden

    Den Haag,
    Netherlands

    Site Not Available

  • Deventer Ziekenhuis

    Deventer,
    Netherlands

    Site Not Available

  • Catharina Ziekenhuis

    Eindhoven,
    Netherlands

    Site Not Available

  • Elkerliek Ziekenhuis

    Helmond,
    Netherlands

    Site Not Available

  • Tergooiziekenhuizen

    Hilversum,
    Netherlands

    Site Not Available

  • Spaarne Ziekenhuis

    Hoofddorp,
    Netherlands

    Site Not Available

  • Westfries Gasthuis

    Hoorn,
    Netherlands

    Site Not Available

  • Rijnland Ziekenhuis

    Leiderdorp,
    Netherlands

    Site Not Available

  • MC Zuiderzee

    Lelystad,
    Netherlands

    Site Not Available

  • Waterlandziekenhuis

    Purmerend,
    Netherlands

    Site Not Available

  • Vlietland Ziekenhuis

    Schiedam,
    Netherlands

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.